Seth P - Search Results

1

Vector-mediated cancer gene therapy: an overview.

Seth P. Seth P. Cancer Biol Ther. 2005 May;4(5):512-7. doi: 10.4161/cbt.4.5.1705. Epub 2005 May 5. Cancer Biol Ther. 2005. PMID: 15908802 Review.

2

Targeting TGFbeta signaling for cancer therapy.

Iyer S, Wang ZG, Akhtari M, Zhao W, Seth P. Iyer S, et al. Among authors: seth p. Cancer Biol Ther. 2005 Mar;4(3):261-6. doi: 10.4161/cbt.4.3.1566. Epub 2005 Mar 28. Cancer Biol Ther. 2005. PMID: 15846079 Review.

3

A modified hTERT promoter-directed oncolytic adenovirus replication with concurrent inhibition of TGFbeta signaling for breast cancer therapy.

Hu Z, Robbins JS, Pister A, Zafar MB, Zhang ZW, Gupta J, Lee KJ, Newman K, Yun CO, Guise T, Seth P. Hu Z, et al. Among authors: seth p. Cancer Gene Ther. 2010 Apr;17(4):235-43. doi: 10.1038/cgt.2009.72. Epub 2009 Oct 2. Cancer Gene Ther. 2010. PMID: 19798122 Free PMC article.

4

Adenovirus-mediated gene transfer to human breast tumor cells: an approach for cancer gene therapy and bone marrow purging.

Seth P, Brinkmann U, Schwartz GN, Katayose D, Gress R, Pastan Ira, Cowan K. Seth P, et al. Cancer Res. 1996 Mar 15;56(6):1346-51. Cancer Res. 1996. PMID: 8640824

5

Biology of breast cancer bone metastasis.

Akhtari M, Mansuri J, Newman KA, Guise TM, Seth P. Akhtari M, et al. Among authors: seth p. Cancer Biol Ther. 2008 Jan;7(1):3-9. doi: 10.4161/cbt.7.1.5163. Epub 2007 Oct 13. Cancer Biol Ther. 2008. PMID: 18059174 Review.

6

Adenovirus-p53-mediated gene therapy of anaplastic large cell lymphoma with t(2;5) in a nude mouse model.

Turturro F, Heineke HL, Drevyanko TF, Link CJ Jr, Seth P. Turturro F, et al. Among authors: seth p. Gene Ther. 2000 Jun;7(11):930-3. doi: 10.1038/sj.gt.3301186. Gene Ther. 2000. PMID: 10849552

7

The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer.

Xu W, Neill T, Yang Y, Hu Z, Cleveland E, Wu Y, Hutten R, Xiao X, Stock SR, Shevrin D, Kaul K, Brendler C, Iozzo RV, Seth P. Xu W, et al. Among authors: seth p. Gene Ther. 2015 Mar;22(3):247-56. doi: 10.1038/gt.2014.110. Epub 2014 Dec 11. Gene Ther. 2015. PMID: 25503693 Free PMC article.

8

The evaluation of adenoviral p53-mediated bystander effect in gene therapy of cancer.

Rizk NP, Chang MY, El Kouri C, Seth P, Kaiser LR, Albelda SM, Amin KM. Rizk NP, et al. Among authors: seth p. Cancer Gene Ther. 1999 Jul-Aug;6(4):291-301. doi: 10.1038/sj.cgt.7700059. Cancer Gene Ther. 1999. PMID: 10419047

9

TGFβ-dependent induction of interleukin-11 and interleukin-8 involves SMAD and p38 MAPK pathways in breast tumor models with varied bone metastases potential.

Gupta J, Robbins J, Jilling T, Seth P. Gupta J, et al. Among authors: seth p. Cancer Biol Ther. 2011 Feb 1;11(3):311-6. doi: 10.4161/cbt.11.3.14096. Epub 2011 Feb 1. Cancer Biol Ther. 2011. PMID: 21099351 Free PMC article.

10

Systemic delivery of a novel liver-detargeted oncolytic adenovirus causes reduced liver toxicity but maintains the antitumor response in a breast cancer bone metastasis model.

Zhang Z, Krimmel J, Zhang Z, Hu Z, Seth P. Zhang Z, et al. Among authors: seth p. Hum Gene Ther. 2011 Sep;22(9):1137-42. doi: 10.1089/hum.2011.003. Epub 2011 Jun 8. Hum Gene Ther. 2011. PMID: 21480822 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

992 results

Search Page